KRAS and lung cancer: Variations were found in 18–20% of lung cancer cases as compared to 6% for world population, suggesting a relative risk of 1.4–2.3, and in vitro transfection experiments showed that variant KRAS alleles resulted in increased KRAS protein expression in A549 lung cancer cells.[86]